Literature DB >> 14713275

Persistent disease after surgery for primary hyperparathyroidism: the long-term outcome.

Gunilla Hedbäck1, Anders Odén.   

Abstract

OBJECTIVE: Nineteen patients with persistent primary hyperparathyroidism were investigated to evaluate their clinical and laboratory status a long time after treatment was ended. The risk of persistent disease and need for extensive surgery for cure, i.e. more than two neck operations, or mediastinal exploration, was also evaluated.
DESIGN: The medical records of 896 consecutive patients operated on for primary hyperparathyroidism were scrutinised at follow-up, a mean of 10.3 Years after surgery. Data on state of health, medication, bone fractures and other diagnoses were collected by use of a questionnaire. There were 600 patients still alive, among whom 13 had persistent disease and they were compared with 509 patients who were cured and without any suspicion of recurrent disease, according to laboratory examination.
RESULTS: Serum calcium and creatinine values had with few exceptions remained stable over the Years. In five patients, serum calcium levels were within the normal range at follow-up. Still, all 19 patients were considered hyperparathyroid. They had substantial cardiovascular morbidity, and their state of health was not as good as that of the patients who were surgically cured. After one operation, 5.5% (95% confidence interval (CI) 4.0-7.2%) had persistent disease, and 2.1% after reoperation. Extensive surgery for cure was performed in 2% of the patients (95% CI 1.1-3.2%).
CONCLUSIONS: We found that the state of health was significantly better for patients with cured primary hyperparathyroidism than for patients with persistent disease, but serious deterioration of laboratory values was uncommon. The result of the present study supports surgical treatment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14713275     DOI: 10.1530/eje.0.1500019

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  4 in total

Review 1.  Surgical treatment of primary hyperparathyroidism: description of techniques and advances in the field.

Authors:  Muhammad Adil Abbas Khan; Sadia Rafiq; Sophocles Lanitis; Farhan Arshad Mirza; Lukasz Gwozdziewicz; Ragheed Al-Mufti; Dimitri J Hadjiminas
Journal:  Indian J Surg       Date:  2013-04-21       Impact factor: 0.656

2.  Localization of Ectopic Mediastinal Parathyroid Adenomas Using Indigo Carmine Injection for Surgical Management: A Preliminary Report.

Authors:  Makoto Kammori; Shinsaku Kanazawa; Hisae Ogata; Natsuki Kanda; Takashi Nagashima; Mahiro Kammori; Toshihisa Ogawa
Journal:  Front Surg       Date:  2022-05-12

3.  The value of intraoperative parathyroid hormone assay in the surgery of mediastinal ectopic parathyroid adenoma (A case series).

Authors:  Sani Rabiou; Sani M Aminou; Boubacar Efared; Hicham Harmouchi; Marwane Lakranbi; Mounia Serraj; Yassine Ouadnouni; Mohamed Smahi
Journal:  Ann Med Surg (Lond)       Date:  2019-06-27

4.  An Unusual Mass of Posterior Mediastinum: A Case of Retrotracheal Parathyroid Adenoma Presenting With Primary Hyperparathyroidism.

Authors:  Sani Rabiou; Boubacar Efared; Sani Aminou; Hicham Harmouchi; Kassim Sidibé; Marouane Lakranbi; Yassine Ouadnouni; Mohamed Smahi
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2018-11-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.